SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001035422-24-000014
Filing Date
2024-07-24
Accepted
2024-07-24 12:56:07
Documents
1
Period of Report
2024-07-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3030
  Complete submission text file 0001035422-24-000014.txt   5292
Mailing Address 3853 NORTHDALE BLVD #268 TAMPA FL 33624
Business Address 3853 NORTHDALE BLVD #268 TAMPA FL 33624 813-606-0060
CTT PHARMACEUTICAL HOLDINGS, INC. (Issuer) CIK: 0001035422 (see all company filings)

IRS No.: 113763974 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 1040 Gold and Silver Ores
(CF Office: 01 Energy & Transportation)

Mailing Address 3853 NORTHDALE BLVD #268 TAMPA FL 33624
Business Address 3853 NORTHDALE BLVD #268 TAMPA FL 33624 813-606-0060
CTT PHARMACEUTICAL HOLDINGS, INC. (Reporting) CIK: 0001035422 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-30651 | Film No.: 241137276
SIC: 1040 Gold and Silver Ores
(CF Office: 01 Energy & Transportation)